Rankings
▼
Calendar
ANIK
Anika Therapeutics, Inc.
$213M
FY 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$120M
-0.7% YoY
Gross Profit
$76M
63.4% margin
Operating Income
-$5M
-4.3% margin
Net Income
-$56M
-47.0% margin
EPS (Diluted)
$-3.83
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
-$2M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$203M
Total Liabilities
$49M
Stockholders' Equity
$154M
Cash & Equivalents
$56M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$120M
$121M
-0.7%
Gross Profit
$76M
$83M
-7.9%
Operating Income
-$5M
$844,000
-704.4%
Net Income
-$56M
-$83M
+31.8%
← Q4 2023
All Quarters
Q1 2024 →
ANIK FY 2024 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena